LIÈGE, Belgium–(BUSINESS WIRE)–CryoTherapeutics, a medical device company developing minimally invasive localized cryotherapy for the treatment of coronary artery disease, today announced the successful treatment of the first patient in its ICECAP clinical trial. The milestone marks an important step in evaluating whether localized cryotherapy can help stabilize vulnerable coronary plaques before they lead to myocardial infarction. During ICECAP screening, the first patient with stable angina
See full post here as originally published on this site
